Skip to main content
Erschienen in: European Journal of Epidemiology 7/2012

01.07.2012 | OPHTHALMIC EPIDEMIOLOGY

Evidence for a considerable decrease in total and cause-specific incidences of blindness in Germany

verfasst von: Heiner Claessen, Jutta Genz, Bernd Bertram, Christoph Trautner, Guido Giani, Iris Zöllner, Andrea Icks

Erschienen in: European Journal of Epidemiology | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

The objectives of this study are to estimate the recent population-based incidences of all-cause and cause-specific blindness in Germany and compare them with results from a similar study conducted in 1994–1998. All blindness allowance recipients newly registered between January 2008 and December 2009 in a region in southern Germany (population, approximately 3.5 million) were assessed and their ophthalmological reports reviewed. The main causes of blindness were identified and their incidences estimated. There were 572 newly registered cases of blindness allowance. The all-cause incidence of blindness (per 100,000 person-years) in the general population was 8.4 (95 % confidence interval, 7.8–9.2), and the highest incidences were for macular degeneration (3.4; 3.0–3.9), diabetic retinopathy (0.8; 0.6–1.1) and glaucoma (0.7; 0.5–0.9). During the last two decades, blindness incidences decreased for all the main causes (standardised to the West German population 1991: 12.3; 11.9–12.7 in 1994–1998 vs. 7.3; 6.7–8.0 in 2008–2009). The highest absolute decrease was for macular degeneration and the highest relative decrease was for cataract. The most frequent main causes of blindness in Germany remained macular degeneration, diabetic retinopathy and glaucoma. Our findings suggest a remarkable decrease in the incidences of blindness, probably because of new diagnostic options and effective treatments.
Literatur
1.
Zurück zum Zitat Wu L, Sun X, Zhou X, Weng C. Causes and 3-year incidence of blindness in Jing-An District, Shanghai, China, 2001–2009. BMC Ophthalmol. 2011;11:10.PubMedCrossRef Wu L, Sun X, Zhou X, Weng C. Causes and 3-year incidence of blindness in Jing-An District, Shanghai, China, 2001–2009. BMC Ophthalmol. 2011;11:10.PubMedCrossRef
2.
Zurück zum Zitat Avisar R, Friling R, Snir M, Avisar I, Weinberger D. Estimation of prevalence and incidence rates and causes of blindness in Israel, 1998–2003. Isr Med Assoc J. 2006;8:880–1.PubMed Avisar R, Friling R, Snir M, Avisar I, Weinberger D. Estimation of prevalence and incidence rates and causes of blindness in Israel, 1998–2003. Isr Med Assoc J. 2006;8:880–1.PubMed
3.
Zurück zum Zitat The Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477–85.CrossRef The Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477–85.CrossRef
4.
Zurück zum Zitat Krumpaszky HG, Klaus V. Zeittrends bei Erblindungsursache [Time trends of causes of blindness]. Klin Monatsbl Augenheilk. 1997;210:9–16 (German). Krumpaszky HG, Klaus V. Zeittrends bei Erblindungsursache [Time trends of causes of blindness]. Klin Monatsbl Augenheilk. 1997;210:9–16 (German).
5.
Zurück zum Zitat Bertram B, Hammers H. Die Prävalenz der Erblindungen wegen diabetischer Retinopathie steigt weiter [The prevalence of loss of eyesight due to diabetic retinopathy continues to rise]. Z Prakt Augenheilkd. 1997;18:181–4 (German). Bertram B, Hammers H. Die Prävalenz der Erblindungen wegen diabetischer Retinopathie steigt weiter [The prevalence of loss of eyesight due to diabetic retinopathy continues to rise]. Z Prakt Augenheilkd. 1997;18:181–4 (German).
6.
Zurück zum Zitat Bunce C, Wormald R. Leading causes of certification for blindness and partial sight in England & Wales. BMC Public Health. 2006;6:58.PubMedCrossRef Bunce C, Wormald R. Leading causes of certification for blindness and partial sight in England & Wales. BMC Public Health. 2006;6:58.PubMedCrossRef
9.
Zurück zum Zitat Ministry of Social Affairs of Baden-Württemberg, personal communication, 2010. Ministry of Social Affairs of Baden-Württemberg, personal communication, 2010.
11.
Zurück zum Zitat Finger RP, Fimmers R, Holz FG, Scholl HP. Prevalence and causes of registered blindness in the largest federal state of Germany. Br J Ophthalmol. 2011;95:1061–7.PubMedCrossRef Finger RP, Fimmers R, Holz FG, Scholl HP. Prevalence and causes of registered blindness in the largest federal state of Germany. Br J Ophthalmol. 2011;95:1061–7.PubMedCrossRef
12.
Zurück zum Zitat Bunce C, Xing W, Wormald R. Causes of blind and partial sight certifications in England and Wales: April 2007–March 2008. Eye. 2010;24:1692–9.PubMedCrossRef Bunce C, Xing W, Wormald R. Causes of blind and partial sight certifications in England and Wales: April 2007–March 2008. Eye. 2010;24:1692–9.PubMedCrossRef
13.
Zurück zum Zitat Trautner C, Haastert B, Giani G, Berger M. Incidence of blindness in southern Germany between 1990 and 1998. Diabetologia. 2001;44:147–50.PubMedCrossRef Trautner C, Haastert B, Giani G, Berger M. Incidence of blindness in southern Germany between 1990 and 1998. Diabetologia. 2001;44:147–50.PubMedCrossRef
14.
Zurück zum Zitat Genz J, Scheer M, Trautner C, Zöllner I, Giani G, Icks A. Reduced incidence of blindness in relation to diabetes mellitus in southern Germany? Diabet Med. 2010;27:1138–43.PubMedCrossRef Genz J, Scheer M, Trautner C, Zöllner I, Giani G, Icks A. Reduced incidence of blindness in relation to diabetes mellitus in southern Germany? Diabet Med. 2010;27:1138–43.PubMedCrossRef
15.
Zurück zum Zitat Trautner C, Haastert B, Richter B, Berger M, Giani G. Incidence of blindness in southern Germany due to glaucoma and degenerative conditions. Invest Ophthalmol Vis Sci. 2003;44:1031–4.PubMedCrossRef Trautner C, Haastert B, Richter B, Berger M, Giani G. Incidence of blindness in southern Germany due to glaucoma and degenerative conditions. Invest Ophthalmol Vis Sci. 2003;44:1031–4.PubMedCrossRef
16.
Zurück zum Zitat Trautner C, Icks A, Haastert B, Plum F, Berger M. Incidence of blindness in relation to diabetes: a population-based study. Diabetes Care. 1997;20:1147–53.PubMedCrossRef Trautner C, Icks A, Haastert B, Plum F, Berger M. Incidence of blindness in relation to diabetes: a population-based study. Diabetes Care. 1997;20:1147–53.PubMedCrossRef
17.
Zurück zum Zitat Icks A, Trautner C, Haastert B, Berger M, Giani G. Blindness due to diabetes: population-based age- and sex-specific incidence rates. Diabet Med. 1997;14:571–5.PubMedCrossRef Icks A, Trautner C, Haastert B, Berger M, Giani G. Blindness due to diabetes: population-based age- and sex-specific incidence rates. Diabet Med. 1997;14:571–5.PubMedCrossRef
18.
Zurück zum Zitat Finger RP, Fimmers R, Holz FG, Scholl HPN. Incidence of blindness and severe visual impairment in Germany—projections for 2030. Invest Ophthalmol Vis Sci. 2011;52:4381–9.PubMedCrossRef Finger RP, Fimmers R, Holz FG, Scholl HPN. Incidence of blindness and severe visual impairment in Germany—projections for 2030. Invest Ophthalmol Vis Sci. 2011;52:4381–9.PubMedCrossRef
19.
Zurück zum Zitat Work Group Epidemiological Methods. Good practice analysis of secondary data: revision after detailed working-over. Gesundheitswesen. 2008;70:54–60 (German).CrossRef Work Group Epidemiological Methods. Good practice analysis of secondary data: revision after detailed working-over. Gesundheitswesen. 2008;70:54–60 (German).CrossRef
20.
Zurück zum Zitat Wolfram C, Pfeiffer N. Blindness and low vision in Germany 1993–2009. Ophthalmic Epidemiol. 2012;19:3–7.PubMedCrossRef Wolfram C, Pfeiffer N. Blindness and low vision in Germany 1993–2009. Ophthalmic Epidemiol. 2012;19:3–7.PubMedCrossRef
21.
Zurück zum Zitat Pauleikhoff D, Kirchhof B, Bertram B, et al. New aspects in the treatment of neovascular age-related macular degeneration: the criteria of re-treatment with anti-VEGF therapy. Ophthalmologe. 2011;108:85–90 (article in German).PubMedCrossRef Pauleikhoff D, Kirchhof B, Bertram B, et al. New aspects in the treatment of neovascular age-related macular degeneration: the criteria of re-treatment with anti-VEGF therapy. Ophthalmologe. 2011;108:85–90 (article in German).PubMedCrossRef
22.
Zurück zum Zitat Current position of the Retinological Society, the German Ophthalmology Society and the Professional Union of Ophthalmologists in Germany. New aspects in the management of exudative age-related macular degeneration. Klin Monbl Augenheilkd. 2009;226:388–95 (article in German). Current position of the Retinological Society, the German Ophthalmology Society and the Professional Union of Ophthalmologists in Germany. New aspects in the management of exudative age-related macular degeneration. Klin Monbl Augenheilkd. 2009;226:388–95 (article in German).
23.
Zurück zum Zitat Ip MS, Scott IU, Brown GC, et al. Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology. Ophthalmology. 2008;115:1837–46.PubMedCrossRef Ip MS, Scott IU, Brown GC, et al. Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology. Ophthalmology. 2008;115:1837–46.PubMedCrossRef
24.
Zurück zum Zitat Bloch SB, Larsen M, Munch IC. Incidence of legal blindness from age-related macular degeneration in Denmark: year 2000 to 2010. Am J Ophthalmol. 2012;153:209-13.e2.CrossRef Bloch SB, Larsen M, Munch IC. Incidence of legal blindness from age-related macular degeneration in Denmark: year 2000 to 2010. Am J Ophthalmol. 2012;153:209-13.e2.CrossRef
25.
Zurück zum Zitat Lin SC, Singh K, Jampel HD, et al. Optic nerve head and retinal nerve fiber layer analysis: a report by the American Academy of Ophthalmology. Ophthalmology. 2007;114:1937–49. Erratum in Ophthalmology. 2008;115:472. Lin SC, Singh K, Jampel HD, et al. Optic nerve head and retinal nerve fiber layer analysis: a report by the American Academy of Ophthalmology. Ophthalmology. 2007;114:1937–49. Erratum in Ophthalmology. 2008;115:472.
26.
Zurück zum Zitat Hoffmeister L, Román R, Comas M, Cots F, Bernal-Delgado E, Castells X. Time-trend and variations in the proportion of second-eye cataract surgery. BMC Health Serv Res. 2007;7:53.PubMedCrossRef Hoffmeister L, Román R, Comas M, Cots F, Bernal-Delgado E, Castells X. Time-trend and variations in the proportion of second-eye cataract surgery. BMC Health Serv Res. 2007;7:53.PubMedCrossRef
27.
Zurück zum Zitat Skaat A, Chetrit A, Belkin M, Kinori M, Kalter-Leibovici O. Time trends in the incidence and causes of blindness in Israel. Am J Ophthalmol. 2012;153(214–21):e1.PubMed Skaat A, Chetrit A, Belkin M, Kinori M, Kalter-Leibovici O. Time trends in the incidence and causes of blindness in Israel. Am J Ophthalmol. 2012;153(214–21):e1.PubMed
28.
Zurück zum Zitat Gunnlaugsdottir E, Arnarsson A, Jonasson F. Five-year incidence of visual impairment and blindness in older Icelanders: the Reykjavik Eye Study. Acta Ophthalmol Scand. 2010;88:358–66. Gunnlaugsdottir E, Arnarsson A, Jonasson F. Five-year incidence of visual impairment and blindness in older Icelanders: the Reykjavik Eye Study. Acta Ophthalmol Scand. 2010;88:358–66.
29.
Zurück zum Zitat Buch H. Fourteen-year incidence of age-related maculopathy and cause-specific prevalence of visual impairment and blindness in a Caucasian population: the Copenhagen City Eye Study. Acta Ophthalmol Scand. 2005;83:400–1.PubMedCrossRef Buch H. Fourteen-year incidence of age-related maculopathy and cause-specific prevalence of visual impairment and blindness in a Caucasian population: the Copenhagen City Eye Study. Acta Ophthalmol Scand. 2005;83:400–1.PubMedCrossRef
Metadaten
Titel
Evidence for a considerable decrease in total and cause-specific incidences of blindness in Germany
verfasst von
Heiner Claessen
Jutta Genz
Bernd Bertram
Christoph Trautner
Guido Giani
Iris Zöllner
Andrea Icks
Publikationsdatum
01.07.2012
Verlag
Springer Netherlands
Erschienen in
European Journal of Epidemiology / Ausgabe 7/2012
Print ISSN: 0393-2990
Elektronische ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-012-9705-7

Weitere Artikel der Ausgabe 7/2012

European Journal of Epidemiology 7/2012 Zur Ausgabe